Trademark search
The 50 closest matches for of record for one attorney.
| Mark | Status | Office | Owner | Classes | Filed |
|---|---|---|---|---|---|
| BIRDIES FOR BRAIN HEALTH | examining | USPTO | AbbVie Inc. | 35, 36, 41 | 2026-09-23 |
| ABBVIE BIRDIES FOR BRAIN HEALTH | examining | USPTO | AbbVie Inc. | 35, 36, 41 | 2026-09-23 |
| ALLODERM RESTORE | examining | USPTO | LifeCell Corporation | 5 | 2026-09-17 |
| CLARITE | pending publication | USPTO | Allergan, Inc. | 10 | 2026-07-23 |
| A A SIGNATURE | examining | USPTO | Allergan Holdings France SAS | 3 | 2026-05-04 |
| AA SIGNATURE | examining | USPTO | Allergan Holdings France SAS | 3, 5, 35, 41, 44 | 2026-05-04 |
| [Design Mark] | pending opposition | USPTO | Allergan Pharmaceuticals International Limited | 5, 42 | 2026-02-27 |
| ADMIRE | allowed | USPTO | AbbVie Inc. | 41 | 2026-01-26 |
| LATISSE LASH | allowed | USPTO | Allergan, Inc. | 5 | 2025-10-31 |
| DART | examining | USPTO | Allergan Pharmaceuticals International Limited | 5, 42 | 2025-10-18 |
| D G | allowed | USPTO | Allergan, Inc. | 10 | 2025-10-08 |
| THE BREAKOUT RHEUM | allowed | USPTO | AbbVie Biotechnology Ltd | 41, 44 | 2025-07-18 |
| ENVIGORATE | examining | USPTO | Allergan Sales, LLC | 3 | 2025-06-17 |
| ABBVIE MEDICAL INSTITUTE | pending issuance | USPTO | AbbVie Inc. | 41, 44 | 2025-05-15 |
| ABBVIE MEDICAL INSTITUTE | pending issuance | USPTO | AbbVie Inc. | 41, 44 | 2025-05-15 |
| A A SIGNATURE | allowed | USPTO | Allergan Holdings France SAS | 5, 35, 41, 44 | 2025-04-29 |
| [Design Mark] | registered | USPTO | Zeltiq Aesthetics, Inc. | 10 | 2025-04-18 |
| OMNIMESH | allowed | USPTO | LifeCell Corporation | 5 | 2025-02-11 |
| THE ONE AND ONLY | registered | USPTO | Allergan, Inc. | 5, 42 | 2024-11-25 |
| MIGRAINE FREEDOM | allowed | USPTO | Allergan, Inc. | 5 | 2024-10-14 |
| BOVYO | allowed | USPTO | Allergan, Inc. | 5 | 2024-09-26 |
| BOZGO | allowed | USPTO | Allergan, Inc. | 5 | 2024-09-26 |
| BOETRY | allowed | USPTO | Allergan, Inc. | 5 | 2024-09-26 |
| BVOE | allowed | USPTO | Allergan, Inc. | 5 | 2024-09-26 |
| INZUBO | allowed | USPTO | Allergan, Inc. | 5 | 2024-09-26 |
| ALLERGAN AESTHETICS NECKOVER | abandoned | USPTO | Allergan, Inc. | 5, 44 | 2024-08-29 |
| VYAFUSER | registered | USPTO | AbbVie AB | 10 | 2024-07-01 |
| BONTI | abandoned | USPTO | Allergan, Inc. | 5 | 2024-04-22 |
| ABBVIE MIGRAINE CAREER CATALYST AWARD | examining | USPTO | Allergan Pharmaceuticals International Limited | 35, 36, 41, 44 | 2024-04-08 |
| CLINDIET | allowed | USPTO | AbbVie Inc. | 44 | 2024-03-25 |
| MIGRAINE FREEDOM | allowed | USPTO | Allergan, Inc. | 44 | 2024-03-14 |
| ALLODERM SELECT DUO | registered | USPTO | Lifecell Corporation | 5 | 2024-03-12 |
| THE ANYTIME, ANYWHERE MIGRAINE MEDICINE | registered | USPTO | Allergan Pharmaceuticals International Limited | 35, 41, 44 | 2024-03-04 |
| BOWEY | allowed | USPTO | Allergan, Inc. | 5 | 2024-02-19 |
| QBOE | allowed | USPTO | Allergan, Inc. | 5 | 2024-02-19 |
| THE ONE AND ONLY | abandoned | USPTO | Allergan, Inc. | 44 | 2024-01-25 |
| ABBVIE | registered | USPTO | AbbVie Inc. | 5 | 2024-01-17 |
| BOEY | allowed | USPTO | Allergan, Inc. | 5 | 2024-01-12 |
| VYALEV | registered | USPTO | AbbVie AB | 5 | 2023-10-30 |
| [Design Mark] | registered | USPTO | AbbVie AB | 5 | 2023-10-09 |
| YUBO | allowed | USPTO | Allergan, Inc. | 5 | 2023-09-11 |
| 3 AREAS, AT LEAST 3 TIMES PER YEAR | abandoned | USPTO | Allergan, Inc. | 44 | 2023-08-22 |
| THE LOOK OF 3 WITH BOTOX COSMETIC | abandoned | USPTO | Allergan, Inc. | 44 | 2023-08-22 |
| 3 AREAS, 64 UNITS, AT LEAST 3 TIMES A YEAR | abandoned | USPTO | Allergan, Inc. | 44 | 2023-08-22 |
| MODEL | abandoned | USPTO | Aliada Therapeutics, Inc. | 5, 42 | 2023-07-28 |
| FORGET YOU GET MIGRAINE MEDICINE | registered | USPTO | Allergan Sales, LLC | 35, 41, 44 | 2023-06-22 |
| UBRELVY COMPLETE | registered | USPTO | Allergan Sales, LLC | 41, 42 | 2023-05-30 |
| NRS | allowed | USPTO | Cerevel Therapeutics, LLC | 5 | 2023-04-19 |
| BOE | abandoned | USPTO | Allergan, Inc. | 5 | 2023-04-12 |
| BOELA | allowed | USPTO | Allergan, Inc. | 5 | 2023-04-12 |